Brintellix 10mg (vortioxetine)

Brintellix is a prescription medication containing the active substance vortioxetine, used for the treatment of major depressive episodes in adults. It was developed through a collaboration between H. Lundbeck A/S and Takeda Pharmaceutical Company. The brand is globally recognized in the psychiatric and neurological field for its unique multimodal mechanism of action.

The product is primarily manufactured by H. Lundbeck A/S in Denmark, where the company maintains its high-tech production and research facilities. As a global leader in brain health, Lundbeck oversees the entire lifecycle of the brand, ensuring stringent quality controls across its international supply chain.

Lundbeck, headquartered in Copenhagen, remains the ultimate owner and primary developer of the drug. The company specializes exclusively in psychiatry and neurology treatments, operating in more than 50 countries to provide specialized care for brain diseases.